medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2014-17-104-107medsovet-783Research ArticleЭндокринологияEndocrinologyСамоконтроль гликемии: взгляд со стороны врача и пациентаSelf-monitoring of glucose: doctor's and patient's viewПогореловаА. С.PogorelovaА. S.noemail@neicon.ruПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияFirst Moscow State Medical University named after I.M. SechenovRussian Federation201430122014017104107Copyright © Погорелова А.С., 20142014Погорелова А.С.Pogorelova А.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/783

Самоконтроль гликемии - основной инструмент в управлении сахарным диабетом (СД), общий для врача и пациента. С одной стороны, самоконтроль гликемии необходим для достижения и поддержания адекватного гликемического контроля, с другой, является инвазивной и стрессовой процедурой. Для того чтобы самоконтроль гликемии был эффективным, необходимо осознание его важности обеими сторонами, а глюкометры должны не только обладать высокой точностью и воспроизводимостью, но минимизировать болевые ощущения и быть максимально удобными для пользователей.

Self-monitoring of blood glucose is the main tool in the management of diabetes mellitus (DM) utilized by both doctor and patient. On the one hand, self-monitoring of blood glucose is necessary to achieve and maintain adequate glycemic control; on the other hand, it is an invasive and stressful procedure. In order to make self-monitoring of glucose effective, both doctor and patient need to be aware of its relevance, while blood glucose meters should be highly accurate and reproducible, as well as pain-minimizing and user-friendly.

самоконтроль гликемиисахарный диабетглюкометрself-monitoring of glucosediabetesblood glucose meterReferencesАлгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой. 6-е изд. М., 2013. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии - неотъемлемый компонент лечения сахарного диабета. Медицинский совет, 2013, 1: 90-97. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care, 2013, 36 (Suppl. 1): S11-S66. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin dependent diabetes mellitus. Journal of Pediatrics, 1997, 130: 257265. Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes and Metabolism, 2008, 34 (6 Pt 1): 612-616. Breton MD, Kovatchev BP Impact of Blood Glucose Self-Monitoring Errors on Glucose Variability, Risk for Hypoglycemia, and Average Glucose Control in Type 1 Diabetes: An In Silico Study. Journal of Diabetes Science and Technology, 2010, 4(3): 562-570. Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, Massucco P et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study Diabetes Care, 2011, 34: 2237-2243. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care, 1999, 22: 233-240. Global Guideline for Type 2 Diabetes. International Diabetes Federation, 2012.Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой. 6-е изд. М., 2013. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии - неотъемлемый компонент лечения сахарного диабета. Медицинский совет, 2013, 1: 90-97. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care, 2013, 36 (Suppl. 1): S11-S66. Anderson B, Ho J, Brackett J, Finkelstein D, Laffel L. Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin dependent diabetes mellitus. Journal of Pediatrics, 1997, 130: 257265. Bragd J, Adamson U, Backlund LB, Lins PE, Moberg E, Oskarsson P Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes and Metabolism, 2008, 34 (6 Pt 1): 612-616. Breton MD, Kovatchev BP Impact of Blood Glucose Self-Monitoring Errors on Glucose Variability, Risk for Hypoglycemia, and Average Glucose Control in Type 1 Diabetes: An In Silico Study. Journal of Diabetes Science and Technology, 2010, 4(3): 562-570. Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, Massucco P et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study Diabetes Care, 2011, 34: 2237-2243. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care, 1999, 22: 233-240. Global Guideline for Type 2 Diabetes. International Diabetes Federation, 2012.Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V et al. Self-monitoring of blood glucose significantly improvesvmetabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study Diabetes and Metabolism, 2003, 29: 587-594.Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V et al. Self-monitoring of blood glucose significantly improvesvmetabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study Diabetes and Metabolism, 2003, 29: 587-594.International Diabetes Federation, 2013: IDF Diabetes Atlas: www.idf.org/diabetesatlasInternational Diabetes Federation, 2013: IDF Diabetes Atlas: www.idf.org/diabetesatlasHalimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, Magnette J. Effect on compliance, acceptability of blood glucose self-monitoring and HbA1c of a self-monitoring system developed according to patient's wishes. The ACCORD study Diabetes and Metabolism, 27 (6): 681-687.Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, Magnette J. Effect on compliance, acceptability of blood glucose self-monitoring and HbA1c of a self-monitoring system developed according to patient's wishes. The ACCORD study Diabetes and Metabolism, 27 (6): 681-687.Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA et al. 10 - Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine, 2008, 359: 1577-1589.Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA et al. 10 - Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine, 2008, 359: 1577-1589.Jansen JP Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Current Medical Research and Opinion, 2006, 22: 671-681.Jansen JP Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Current Medical Research and Opinion, 2006, 22: 671-681.Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia, 2006, 49: 271-278.Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia, 2006, 49: 271-278.Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol, 1994, 31: 215-219.Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol, 1994, 31: 215-219.Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. British Journal of General Practice, 2004, 54: 183-188.Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. British Journal of General Practice, 2004, 54: 183-188.Protection of Laboratory Workers from Occupationally Acquired infections; Approved Guideline - Third Edition. Clinical and Laboratory Standards Institute (CLSI), document M 29-A 3 (ISBN 1-56238-567-4). CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 190871898, 2005, USA.Protection of Laboratory Workers from Occupationally Acquired infections; Approved Guideline - Third Edition. Clinical and Laboratory Standards Institute (CLSI), document M 29-A 3 (ISBN 1-56238-567-4). CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 190871898, 2005, USA.Raine C.H. 3-rd. Self-monitored blood glucose: a common pitfall. Endocrine Practice, 2003, 9: 137-139.Raine C.H. 3-rd. Self-monitored blood glucose: a common pitfall. Endocrine Practice, 2003, 9: 137-139.Reichard P, Phil M. Mortality and treatment side effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention study. Diabetes, 1994, 43 (2): 313-317.Reichard P, Phil M. Mortality and treatment side effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention study. Diabetes, 1994, 43 (2): 313-317.Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes, 1993, 42 (11): 1549-1554.Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes, 1993, 42 (11): 1549-1554.Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Current Medical Research and Opinion, 2005, 21: 173-184.Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Current Medical Research and Opinion, 2005, 21: 173-184.The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. New England Journal of Medicine, 1993, 329 (14): 977-986.The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. New England Journal of Medicine, 1993, 329 (14): 977-986.UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998, 352 (9131): 837-853.UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998, 352 (9131): 837-853.Weber C, Schneider B, Lodwig V, Holm MV, Neeser K. Cost impact of blood glucose self-monitoring on complications of type 2 diabetes: a Swiss perspective (ROSSO study No. 11). SWISS MEDical WeeKLY, 2007, 137: 545-550.Weber C, Schneider B, Lodwig V, Holm MV, Neeser K. Cost impact of blood glucose self-monitoring on complications of type 2 diabetes: a Swiss perspective (ROSSO study No. 11). SWISS MEDical WeeKLY, 2007, 137: 545-550.

The authors declare that there are no conflicts of interest present.